UBS Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-142
| Closed | -$75 | – | 9706 |
|
|
2025
Q1 | $75 | Sell |
142
-4,497
| -97% | -$2.38K | ﹤0.01% | 8660 |
|
|
2024
Q4 | $24.4K | Buy |
4,639
+4,627
| +38,558% | +$24.3K | ﹤0.01% | 6520 |
|
|
2024
Q3 | $171 | Buy |
+12
| New | +$171 | ﹤0.01% | 7877 |
|
|
2024
Q2 | – | Sell |
-125
| Closed | -$12.6K | – | 8277 |
|
|
2024
Q1 | $12.6K | Sell |
125
-22
| -15% | -$2.23K | ﹤0.01% | 5957 |
|
|
2023
Q4 | $3.48K | Sell |
147
-140
| -49% | -$3.31K | ﹤0.01% | 6753 |
|
|
2023
Q3 | $5.79K | Buy |
+287
| New | +$5.79K | ﹤0.01% | 6204 |
|
|
2022
Q4 | – | Sell |
-78
| Closed | -$2K | – | 9915 |
|
|
2022
Q3 | $2K | Buy |
+78
| New | +$2K | ﹤0.01% | 8693 |
|